Tag Archives: Pharmaceutical Market Research Reports

The Global Pharmaceuticals Market to reach $971.1 billion by 2016

2013-03-22
Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive...

Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics – Pipeline Assessment and Market Forecasts to 2019

2012-02-28
GlobalData, the industry analysis specialist, has released its new report, “Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics – Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information...

Laryngeal Cancer Therapeutics – Pipeline Assessment and Market Forecasts to 2019

2012-02-28
GlobalData, the industry analysis specialist, has released its new report, “Laryngeal Cancer Therapeutics – Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global...

Branded Prescription Pharmaceutical Sales Outlook to 2016

2012-02-09
Report Summary In 2011, the Branded PharmaVitae Universe achieved sales of $558bn having experienced a compound annual growth rate (CAGR) of 9.3% between 2003 and 2010, and a net sales growth of $253bn. However, during 2011–16 sales are forecast...

Vitiligo Therapeutics – Pipeline Assessment and Market Forecasts to 2019

2012-02-07
This report is an essential source of information and analysis on the global Vitiligo Therapeutics market. The report identifies the key trends shaping and driving the global Vitiligo Therapeutics market. The report also provides insights on...

Companion Diagnostics in Personalized Medicine and Cancer Therapy

2012-02-07
Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy. This linkage could be important in the therapeutic application and clinical outcome of...

Immunomodulators Market to 2017 – Immunosuppressant Antibodies to Replace Antimetabolites as the Highest Value Sector by 2017

2012-02-01
Immunosuppressants holds a 64% Market Share of the Immunomodulators Market with More Products in the Pipeline than Immunostimulants This report provides insight about immunomodulators sales forecasts until 2017. Immunomodulators markets in...

Vaccine Production (Trends, Techniques, Key Players, Spending Estimates and Forecasts)

2012-02-01
Report Summary The considerable revenue growth in the vaccine market over the past ten years suggests the amount of vaccine production and the techniques of vaccine production will need to adapt to match a revived industry. This report, Vaccine...

Product Profiles: Pipeline Antibacterials – Gram-negative combination antibiotics show promise in MRSA-focused pipeline

2012-01-23
Report Summary The majority of the drugs in the late stage of the pipeline are being developed to target Gram-positive infections, including methicillin-resistant Staphylococcus aureus (MRSA). Progress has been slow, with many drugs held up...

Antifungals Market to 2017 – Generic Erosion of Major Polyenes, Azoles, Allylamines and Echinocandins to Slow Value Growth

2012-01-16
Report Summary GBI Research, the leading business intelligence provider has released its latest research Antifungals Market to 2017 – Generic Erosion of Major Polyenes, Azoles, Allylamines and Echinocandins to Slow Value Growth, which...
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy